Strides And Orbicular Agree Alliance To Develop Nasal Sprays

Targeting Four Products Worth $400m In Markets Including Europe And US

 
• By David Wallace
  
Nasal sprays on green background
Strides and Orbicular have struck a deal to develop nasal sprays • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business